Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

AMD and the alternative complement pathway: genetics and functional implications.

Tan PL, Bowes Rickman C, Katsanis N.

Hum Genomics. 2016 Jun 21;10(1):23. doi: 10.1186/s40246-016-0079-x. Review.

2.

Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages.

Schick T, Altay L, Viehweger E, Hoyng CB, den Hollander AI, Felsch M, Fauser S.

PLoS One. 2016 Jun 3;11(6):e0156778. doi: 10.1371/journal.pone.0156778. eCollection 2016.

3.

The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review.

Cooke Bailey JN, Hoffman JD, Sardell RJ, Scott WK, Pericak-Vance MA, Haines JL.

J Clin Med. 2016 Mar 4;5(3). pii: E31. doi: 10.3390/jcm5030031. Review.

4.

Mutations in CTNNA1 cause butterfly-shaped pigment dystrophy and perturbed retinal pigment epithelium integrity.

Saksens NT, Krebs MP, Schoenmaker-Koller FE, Hicks W, Yu M, Shi L, Rowe L, Collin GB, Charette JR, Letteboer SJ, Neveling K, van Moorsel TW, Abu-Ltaif S, De Baere E, Walraedt S, Banfi S, Simonelli F, Cremers FP, Boon CJ, Roepman R, Leroy BP, Peachey NS, Hoyng CB, Nishina PM, den Hollander AI.

Nat Genet. 2016 Feb;48(2):144-51. doi: 10.1038/ng.3474. Epub 2015 Dec 21.

5.

Gene expression regulation in retinal pigment epithelial cells induced by viral RNA and viral/bacterial DNA.

Brosig A, Kuhrt H, Wiedemann P, Kohen L, Bringmann A, Hollborn M.

Mol Vis. 2015 Aug 31;21:1000-16. eCollection 2015.

6.

Age-related macular degeneration: insights into inflammatory genes.

Cascella R, Ragazzo M, Strafella C, Missiroli F, Borgiani P, Angelucci F, Marsella LT, Cusumano A, Novelli G, Ricci F, Giardina E.

J Ophthalmol. 2014;2014:582842. doi: 10.1155/2014/582842. Epub 2014 Nov 12. Review.

7.

A survey on computer aided diagnosis for ocular diseases.

Zhang Z, Srivastava R, Liu H, Chen X, Duan L, Kee Wong DW, Kwoh CK, Wong TY, Liu J.

BMC Med Inform Decis Mak. 2014 Aug 31;14:80. doi: 10.1186/1472-6947-14-80. Review.

8.

The impact of the human genome project on complex disease.

Bailey JN, Pericak-Vance MA, Haines JL.

Genes (Basel). 2014 Jul 16;5(3):518-35. doi: 10.3390/genes5030518.

9.
10.

Age-related macular degeneration: genetics and biology coming together.

Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A.

Annu Rev Genomics Hum Genet. 2014;15:151-71. doi: 10.1146/annurev-genom-090413-025610. Epub 2014 Apr 16. Review.

11.

Variability of the transferrin receptor 2 gene in AMD.

Wysokinski D, Blasiak J, Dorecka M, Kowalska M, Robaszkiewicz J, Pawlowska E, Szaflik J, Szaflik JP.

Dis Markers. 2014;2014:507356. doi: 10.1155/2014/507356. Epub 2014 Feb 6.

12.

Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study.

Semba RD, Cotch MF, Gudnason V, EirĂ­ksdottir G, Harris TB, Sun K, Klein R, Jonasson F, Ferrucci L, Schaumberg DA.

JAMA Ophthalmol. 2014 Apr 1;132(4):464-70. doi: 10.1001/jamaophthalmol.2013.7664.

13.

Genetic and environmental underpinnings to age-related ocular diseases.

Seddon JM.

Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF28-30. doi: 10.1167/iovs.13-13234. Review.

14.

Genetic and Epigenetic Regulation in Age-related Macular Degeneration.

Wei L, Chen P, Lee JH, Nussenblatt RB.

Asia Pac J Ophthalmol (Phila). 2013 Jul-Aug;2(4):269-74.

15.

Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis.

Naj AC, Scott WK, Courtenay MD, Cade WH, Schwartz SG, Kovach JL, Agarwal A, Wang G, Haines JL, Pericak-Vance MA.

Ann Hum Genet. 2013 May;77(3):215-31. doi: 10.1111/ahg.12011.

16.

Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.

Holliday EG, Smith AV, Cornes BK, Buitendijk GH, Jensen RA, Sim X, Aspelund T, Aung T, Baird PN, Boerwinkle E, Cheng CY, van Duijn CM, Eiriksdottir G, Gudnason V, Harris T, Hewitt AW, Inouye M, Jonasson F, Klein BE, Launer L, Li X, Liew G, Lumley T, McElduff P, McKnight B, Mitchell P, Psaty BM, Rochtchina E, Rotter JI, Scott RJ, Tay W, Taylor K, Teo YY, Uitterlinden AG, Viswanathan A, Xie S; Wellcome Trust Case Control Consortium 2, Vingerling JR, Klaver CC, Tai ES, Siscovick D, Klein R, Cotch MF, Wong TY, Attia J, Wang JJ.

PLoS One. 2013;8(1):e53830. doi: 10.1371/journal.pone.0053830. Epub 2013 Jan 11.

17.

Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy.

Cheng Y, Huang L, Li X, Zhou P, Zeng W, Zhang C.

PLoS One. 2013;8(1):e53665. doi: 10.1371/journal.pone.0053665. Epub 2013 Jan 9.

18.

Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population.

Kang HK, Yoon MH, Lee DH, Chin HS.

Korean J Ophthalmol. 2012 Dec;26(6):414-22. doi: 10.3341/kjo.2012.26.6.414. Epub 2012 Nov 12.

19.

Hypomethylation of the IL17RC promoter associates with age-related macular degeneration.

Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z, Liu X, Ni J, Dagur P, Sen HN, Jawad S, Ling D, Park S, Chakrabarty S, Meyerle C, Agron E, Ferris FL 3rd, Chew EY, McCoy JP, Blum E, Francis PJ, Klein ML, Guymer RH, Baird PN, Chan CC, Nussenblatt RB.

Cell Rep. 2012 Nov 29;2(5):1151-8. doi: 10.1016/j.celrep.2012.10.013. Epub 2012 Nov 21.

20.

An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration.

Wysokinski D, Zaras M, Dorecka M, Waszczyk M, Szaflik J, Blasiak J, Szaflik JP.

Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1057-65. doi: 10.1007/s00417-012-1966-z. Epub 2012 Feb 29.

Items per page

Supplemental Content

Write to the Help Desk